Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu ...

NanoViricides, Inc. (NYSE American: NNVC) has filed its quarterly report for the period ending Dec. 31, 2024, with the SEC, reporting cash and cash e ...

(NNVC) on Friday reported a loss of $2 million in its fiscal second quarter. On a per-share basis, the Shelton, Connecticut-based company said it had a loss of 14 cents. This story was generated by ...

SHELTON, Conn. (AP) — SHELTON, Conn. (AP) — NanoViricides Inc. (NNVC) on Friday reported a loss of $2 million in its fiscal second quarter. On a per-share basis, the Shelton, Connecticut-based ...

Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / February 19, 2025 / NanoViricides ...

The company said, “We reported that, as of December 31, 2024, we had cash and cash equivalent current assets balance of approximately $3.96 ...

MVB Financial Corp. ("MVB Financial," "MVB," or the "Company") has declared a quarterly cash dividend of $0.17 per share, maintaining the dividend declared in the previous quarter for shareholders of ...

MIAMI, FL / ACCESS Newswire / February 19, 2025 / SMX Ltd. filed a 6-K announcing Nasdaq listing compliance, an important milestone highlighting the company's resilience and strategic execution during ...

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.

After hours: February 10 at 6:29:20 p.m. EST ...